SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 6.500-6.3%Nov 14 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Boyce Burge who wrote (10)7/14/1997 1:17:00 PM
From: Vector1 of 557
 
News on TGEN.



--------------------------------------------------------------------------------
07/14 11:43A (DJ) Targeted Genetics Gets Patent Notice For Gene Therapy >TGEN
Story 2528 (TGEN, I/BTC, I/MTC, N/DJN, N/DJWI, N/PAT, M/TEC, P/DPH, R/NME...)
SEATTLE (Dow Jones)--Targeted Genetics Corp. (TGEN) received a notice of
allowance for a U.S. patent covering versions of the protein used to correct
the defect in cystic fibrosis.
In a press release Monday, the company said genes encoding these proteins
can be delivered with any gene therapy vector.
The company said the patent covers truncated or shortened versions of the
cystic fibrosis transmembrane conductance regulator protein which can maintain
function in conducting cloride across the surface of lungs, a goal of cystic
fibrosis gene therapy.
Targeted Genetics develops gene and cell therapy products.
(END) DOW JONES NEWS 07-14-97
11:43 AM
Additional Codes (R/PRM, R/US, R/USW, R/WA)

V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext